Supply Chain

We Are Blood, the only blood supplier for hospitals in central Texas, is running dangerously low on O-negative blood and platelet donations, according to KVUE.

Nearly a quarter (23 percent) of prescriptions filled in 2013 were likely overpaid, according to recent research out of the USC Leonard D. Schaeffer Center for Health Policy and Economics in Los Angeles.

CVS stands accused of boosting its profits by overbilling Medicaid managed-care companies for medications and underpaying pharmacists for the drugs in an effort to push out competition in Ohio — a charge the pharmacy giant denies, according to The Columbus…

A recent article from Cardinal Health shares best practices for benchmarking at your hospital pharmacy

Toronto-based Laborie Medical Technologies will acquire Minnetonka, Minn.-based Cogentix Medical for $239 million.

The FDA placed a clinical hold on Advaxis' combination cancer drug study March 9 after a patient death occurred last month.

Hartford (Conn.) HealthCare, formed through a series of mergers and acquisitions, unites a diverse group of healthcare providers.

In a recent interview, Joe Swartz, the administrative director of business transformation for Franciscan St. Francis Health, spoke about his organization’s ten years of effort in engaging every staff member in “kaizen,” or continuous improvement.

Biogen shared plans Monday to buy Pfizer's experimental neurology drug in a deal worth up to $590 million, reports Reuters.

Here are the four latest drugs or medical devices approved by the FDA this week.